🗣️Notice of Ohio Advisory Committee Meeting on Civil Rights
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the Ohio Advisory Committee (Committee) to the U.S. Commission on Civil Rights will hold a public meeting via Zoom. The purpose of this meeting is to discuss outreach updates and briefing planning for the Committee's civil rights project on antisemitism in Ohio.
Learn More🏦FDIC Sunshine Act Meeting
The Federal Deposit Insurance Corporation (FDIC) will hold a public meeting to discuss vital matters, including updates on the Deposit Insurance Fund Restoration Plan. The board's discussions may influence banking policies and regulatory frameworks affecting financial institutions and stakeholders. Participants can observe the meeting via webcast for further engagement.
Learn More🏛️IRS Taxpayer Advocacy Panel Meeting
An open meeting of the Taxpayer Advocacy Panel's Joint Committee Project Committee will be conducted. The Taxpayer Advocacy Panel is soliciting public comments, ideas, and suggestions to improve customer service at the Internal Revenue Service. This meeting will be held as a virtual video conference via the Microsoft Teams platform.
Learn More🐟South Atlantic Fishery Management Council Public Meeting Details
The South Atlantic Fishery Management Council (Council) will hold meetings of the following: Snapper Grouper Commercial Sub- Committee; Mackerel Cobia Committee; Snapper Grouper Committee; and Joint Habitat & Ecosystem and Shrimp Committee. The meeting week will also include a formal public comment session and meetings of the Full Council.
Learn More🏛️IRS Electronic Tax Administration Advisory Committee Meeting Notice
The Electronic Tax Administration Advisory Committee will hold a public meeting.
Learn More🌊Public Meeting Notice for Colorado River Basin Salinity Control Council
The Bureau of Reclamation (Reclamation) is publishing this notice to announce that a Federal Advisory Committee meeting of the Colorado River Basin Salinity Control Advisory Council (Council) will take place. The meeting is open to the public.
Learn More💊FDA Announces Public Meeting on Generic Drug User Fee Reauthorization
The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2028 to 2032. At the end of September 2027, new legislation will be required for FDA to continue to collect generic drug user fees for future FYs. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that before FDA begins negotiations with the regulated industry on GDUFA reauthorization, we publish a notice in the Federal Register requesting public input on the reauthorization; hold a public meeting at which the public may present its views on the reauthorization, including specific suggestions for changes to the goals referred to in the GDUFA Reauthorization Performance Goals and Program Enhancements Fiscal Years 2023-2027 (i.e., the GDUFA III Commitment Letter) (https://www.fda.gov/industry/ generic-drug-user-fee-amendments/gdufa-iii-reauthorization); provide a period of 30 days after the public meeting to obtain written comments from the public; and publish the comments on FDA's website. FDA invites public comment on the GDUFA program and suggestions regarding the features FDA should propose for the next GDUFA program cycle. These comments will be published and available on FDA's website.
Learn More🌊NOAA Hydrographic Services Review Panel Meeting - Engage Stakeholders
NOAA will hold a virtual Hydrographic Services Review Panel (HSRP) Federal Advisory Committee public meeting on Thursday, May 29, 2025. NOAA will accept public comments in advance and during the virtual meeting.
Learn More💊FDA Meeting on Reauthorization of Prescription Drug User Fee Act
The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032. PDUFA authorizes FDA to collect user fees to support the process for the review of human drug applications. The current legislative authority for PDUFA expires in September 2027. At that time, new legislation will be required for FDA to continue collecting prescription drug user fees in future fiscal years. The Federal Food, Drug, and Cosmetic Act (FD&C Act) directs that FDA begin the PDUFA reauthorization process by publishing a notice in the Federal Register requesting public input and holding a public meeting where the public may present its views on the reauthorization. FDA invites public comment as the Agency begins the process to reauthorize the program in FYs 2028 through 2032. These comments will be published and available on FDA's website.
Learn More🗣️Public Meeting Notice for New Jersey Advisory Committee to USCCR
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the New Jersey Advisory Committee (Committee) to the U.S. Commission on Civil Rights will a public meeting via Zoom. The purpose is for the committee to discuss topic ideas.
Learn More